{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:29:45Z","timestamp":1791203385584,"version":"4.2.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tcmonline.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.tcm.2015.12.003","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T09:46:53Z","timestamp":1452764813000},"page":"423-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Recent progress in understanding the natural and clinical histories of the Marfan syndrome"],"prefix":"10.1016","volume":"26","author":[{"given":"Reed E.","family":"Pyeritz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2015.12.003_bib1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJM197204132861502","article-title":"Life expectancy and causes of death in the Marfan syndrome","volume":"286","author":"Murdoch","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2015.12.003_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","article-title":"Progression of aortic dilatation and the benefit of long-term \u03b2-adrenergic blockade in Marfan\u2019s syndrome","volume":"330","author":"Shores","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2015.12.003_bib3","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJM199904293401702","article-title":"Surgery for ascending aortic disease in Marfan patients: a multi-center study","volume":"340","author":"Gott","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2015.12.003_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.tcm.2015.12.003_bib5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The revised Ghent nosology for the Marfan syndrome","volume":"47","author":"Loeys","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.tcm.2015.12.003_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0002-9149(00)80066-1","article-title":"Life expectancy in the Marfan syndrome","volume":"75","author":"Silverman","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2015.12.003_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1399-0004.1998.tb03714.x","article-title":"Life expectancy in British Marfan syndrome populations","volume":"54","author":"Gray","year":"1998","journal-title":"Clin Genet"},{"key":"10.1016\/j.tcm.2015.12.003_bib8","first-page":"1329","article-title":"Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome","volume":"124","author":"Cook","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tcm.2015.12.003_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1399-0004.2009.01197.x","article-title":"Neuromuscular features in Marfan syndrome","volume":"76","author":"Voermans","year":"2009","journal-title":"Clin Genet"},{"key":"10.1016\/j.tcm.2015.12.003_bib10","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1016\/j.ijcard.2013.12.131","article-title":"Should we systematically screen for peripheral arterial aneurysms in all patients with Marfan syndrome?","volume":"172","author":"Gaertner","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2015.12.003_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000340008","article-title":"The impact of obstructive sleep apnea on aortic disease in Marfan\u2019s syndrome","volume":"86","author":"Kohler","year":"2013","journal-title":"Respiration"},{"key":"10.1016\/j.tcm.2015.12.003_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCGENETICS.115.001040","article-title":"Potential phenotype-genotype correlation in Marfan syndrome: when less is more?","volume":"8","author":"Dietz","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.tcm.2015.12.003_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.1192152","article-title":"Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism","volume":"332","author":"Habashi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tcm.2015.12.003_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.matbio.2015.05.002","article-title":"The fibrillin microfibril scaffold: a niche for growth factors and mechanosensation","volume":"47","author":"Sengle","year":"2015","journal-title":"Matrix Biol"},{"key":"10.1016\/j.tcm.2015.12.003_bib15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.108.841981","article-title":"Circulating transforming growth factor-beta in Marfan syndrome","volume":"120","author":"Matt","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2015.12.003_bib16","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.ijcard.2013.03.033","article-title":"Circulating transforming growth factor-\u03b2 as a prognostic biomarker in Marfan syndrome","volume":"168","author":"Franken","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2015.12.003_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tcm.2015.12.003_bib18","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1111\/j.1651-2227.2011.02293.x","article-title":"The effect of beta-blocker therapy on progressive aortic dilatation in children and adolescents with Marfan\u2019s syndrome: a meta-analysis","volume":"100","author":"Gao","year":"2011","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.tcm.2015.12.003_bib19","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan syndrome","volume":"371","author":"Lacro","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2015.12.003_bib20","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","article-title":"Marfan sartan: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Milleron","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2015.12.003_bib21","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic root-root dilatation in Marfan\u2019s syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2015.12.003_bib22","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","article-title":"Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial","volume":"34","author":"Groenink","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2015.12.003_bib23","doi-asserted-by":"crossref","first-page":"e08648","DOI":"10.7554\/eLife.08648","article-title":"A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome","author":"Doyle","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.tcm.2015.12.003_bib24","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.jtcvs.2014.02.021","article-title":"Early and 1-year outcomes of aortic root surgery in patients with Marfan syndrome: a prospective, multicenter, comparative study","volume":"147","author":"Coselli","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.tcm.2015.12.003_bib25","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jacc.2015.07.041","article-title":"Outcomes of aortic valve-sparing operations in Marfan syndrome","volume":"66","author":"David","year":"2015","journal-title":"J A Coll Cardiol"},{"key":"10.1016\/j.tcm.2015.12.003_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/TACG.S60472","article-title":"Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome","volume":"8","author":"von Kodolistsch","year":"2015","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.tcm.2015.12.003_bib28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/gim.2014.63","article-title":"Loeys-Dietz syndrome is a specific phenotype and not a concomitant of any mutation in any gene involved in TGF-\u03b2 signaling","volume":"16","author":"Pyeritz","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.tcm.2015.12.003_bib29","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/0002-9149(93)90523-F","article-title":"Aortic dimensions in tall men and women","volume":"71","author":"Reed","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2015.12.003_bib30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1399-0004.2011.01646.x","article-title":"Critical appraisal of the revised Ghent criteria for diagnosis of Marfan syndrome","volume":"80","author":"Radonic","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.tcm.2015.12.003_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/jhg.2015.10","article-title":"Decreased frequency of FBN1 missense variants in Ghent criteria-positive Marfan syndrome and characterization of novel FBN1 variants","volume":"60","author":"Baudhuin","year":"2015","journal-title":"J Hum Genet"},{"key":"10.1016\/j.tcm.2015.12.003_bib32","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/hmg\/ddv037","article-title":"The clinical presentation of Marfan syndrome is modulated by expression of wild-type FBN1 allele","volume":"24","author":"Aubart","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.tcm.2015.12.003_bib33","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.110.990549","article-title":"Increased vertebral artery tortuosity index is associated with adverse outcomes in children and young adults with connective tissue disorders","volume":"124","author":"Morris","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2015.12.003_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2015.05.072","article-title":"Increased aortic tortuosity indicates a more severe aortic phenotype in adults with Marfan syndrome","volume":"194","author":"Franken","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2015.12.003_bib35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/CIRCGENETICS.114.000950","article-title":"Beneficial outcome of losartan therapy depends on type of FBN1 mutation in Marfan syndrome","volume":"8","author":"Franken","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.tcm.2015.12.003_bib36","article-title":"Cardiac remodeling in the mouse model of Marfan syndrome develops into two distinctive phenotypes","author":"Tae","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.tcm.2015.12.003_bib37","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ahj.2015.01.011","article-title":"Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: a report from the Marfan Treatment Trialists\u2019 Collaboration","volume":"169","author":"Pitcher","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2015.12.003_bib38","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/jama.298.13.1539","article-title":"Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial","volume":"298","author":"Ahimastos","year":"2007","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2015.12.003_bib39","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1161\/CIRCULATIONAHA.110.012187","article-title":"Pravastatin reduces Marfan aortic dilatation","volume":"124","author":"McLoughlin","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2015.12.003_bib40","doi-asserted-by":"crossref","first-page":"e107221","DOI":"10.1371\/journal.pone.0107221","article-title":"No beneficial effect of general and specific anti-inflammatory therapies on aortic dilatation in Marfan mice","volume":"9","author":"Franken","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tcm.2015.12.003_bib42","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijcard.2015.06.015","article-title":"Effect of personalized external aortic root support on aortic root motion and distension in Marfan syndrome patients","volume":"197","author":"Izgi","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2015.12.003_bib43","doi-asserted-by":"crossref","first-page":"E898","DOI":"10.1002\/ccd.24725","article-title":"Endovascular treatment of type B dissection in patients with Marfan syndrome: mid-term outcomes and aortic remodeling","volume":"82","author":"Eid-Lidt","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.tcm.2015.12.003_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ejcts\/ezt636","article-title":"Endovascular therapy in patients with genetically triggered thoracic aortic disease: applications and short- and mid-term outcomes","volume":"46","author":"Preventza","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.tcm.2015.12.003_bib45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/HCO.0000000000000023","article-title":"Heritable thoracic aortic disorders","volume":"29","author":"Pyeritz","year":"2014","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.tcm.2015.12.003_bib46","article-title":"Histopathology of aortic complications in bicuspid aortic valve versus Marfan syndrome: relevance for therapy","author":"Grewal","year":"2015","journal-title":"Heart Vessels"},{"key":"10.1016\/j.tcm.2015.12.003_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjca.2015.11.007","article-title":"The expanding clinical spectrum of extra cardiovascular and cardiovascular manifestations of heritable thoracic aortic aneurysms and dissections","author":"Bradley","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.tcm.2015.12.003_bib48","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12945\/j.aorta.2014.14-032","article-title":"Heterogeneity in the segmental development of the aortic tree: impact on management of genetically triggered aortic aneurysms","volume":"2","author":"Sherif","year":"2014","journal-title":"Aorta"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173816000098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173816000098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T13:30:33Z","timestamp":1567517433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173816000098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1050173816000098"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2015.12.003","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent progress in understanding the natural and clinical histories of the Marfan syndrome","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2015.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}